D.E. Shaw & Co’s Exact Sciences EXAS Stock Holding History

D.E. Shaw & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-72,000	Closed	-$4.05M	–	4396
2024 Q4	$4.05M	Hold	72,000	–	–	﹤0.01%	2143
2024 Q3	$4.9M	Sell	72,000 -27,100	-27%	-$1.53M	﹤0.01%	1972
2024 Q2	$4.19M	Buy	99,100 +92,900	+1,498%	+$5.11M	﹤0.01%	1998
2024 Q1	$428K	Sell	6,200 -23,800	-79%	-$1.51M	﹤0.01%	3559
2023 Q4	$2.22M	Hold	30,000	–	–	﹤0.01%	2590
2023 Q3	$2.05M	Hold	30,000	–	–	﹤0.01%	2547
2023 Q2	$2.82M	Hold	30,000	–	–	﹤0.01%	2343
2023 Q1	$2.03M	Hold	30,000	–	–	﹤0.01%	2684
2022 Q4	$1.49M	Hold	30,000	–	–	﹤0.01%	3169
2022 Q3	$975K	Sell	30,000 -21,400	-42%	-$882K	﹤0.01%	3616
2022 Q2	$2.02M	Sell	51,400 -48,100	-48%	-$2.57M	﹤0.01%	3064
2022 Q1	$6.96M	Sell	99,500 -27,000	-21%	-$1.97M	0.01%	1960
2021 Q4	$9.85M	Buy	126,500 +54,500	+76%	+$4.81M	0.01%	1678
2021 Q3	$6.87M	Buy	72,000 +40,000	+125%	+$4.22M	0.01%	1830
2021 Q2	$3.98M	Buy	32,000 +12,000	+60%	+$1.43M	﹤0.01%	2247
2021 Q1	$2.64M	Sell	20,000 -10,000	-33%	-$1.37M	﹤0.01%	2357
2020 Q4	$3.98M	Buy	30,000 +19,300	+180%	+$2.33M	﹤0.01%	2052
2020 Q3	$1.09M	Sell	10,700 -22,500	-68%	-$1.94M	﹤0.01%	2802
2020 Q2	$2.89M	Buy	33,200 +1,700	+5%	+$136K	﹤0.01%	2110
2020 Q1	$1.83M	Sell	31,500 -13,000	-29%	-$1.06M	﹤0.01%	2238
2019 Q4	$4.12M	Sell	44,500 -400	-0.9%	-$35.2K	﹤0.01%	1883
2019 Q3	$4.06M	Hold	44,900	–	–	0.01%	1812
2019 Q2	$5.3M	Buy	44,900 +6,000	+15%	+$605K	0.01%	1552
2019 Q1	$3.37M	Sell	38,900 -94,100	-71%	-$8.01M	﹤0.01%	1803
2018 Q4	$8.39M	Buy	133,000 +60,000	+82%	+$4.12M	0.01%	1204
2018 Q3	$5.76M	Hold	73,000	–	–	0.01%	1491
2018 Q2	$4.37M	Buy	73,000 +35,000	+92%	+$1.88M	0.01%	1635
2018 Q1	$1.53M	Sell	38,000 -119,000	-76%	-$5.8M	﹤0.01%	2220
2017 Q4	$8.25M	Buy	157,000 +75,200	+92%	+$4.02M	0.01%	1149
2017 Q3	$3.85M	Buy	81,800 +2,800	+4%	+$113K	0.01%	1572
2017 Q2	$2.79M	Buy	79,000 +10,000	+14%	+$309K	﹤0.01%	1760
2017 Q1	$1.63M	Buy	69,000 +10,000	+17%	+$198K	﹤0.01%	1971
2016 Q4	$788K	Hold	59,000	–	–	﹤0.01%	2602
2016 Q3	$1.1M	Buy	+59,000	New	+$1.04M	﹤0.01%	2337

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

D.E. Shaw & Co's EXAS Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 502,142 shares — an estimated $51M sold.

D.E. Shaw & Co first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $216M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

D.E. Shaw & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 502,142 Exact Sciences shares in Q1 2026, an estimated $51M.
D.E. Shaw & Co first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
D.E. Shaw & Co's Exact Sciences position peaked at $216M in Q1 2019.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.